Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Plos One|April 20, 2018
Derivation and internal validation of a mortality risk index for aged people living with HIV: The Dat'AIDS scoreMaxime Hentzien, Cyrille Delpierre, Pascal Pugliese, et al.
HIV Medicine|June 3, 2009
A large French prospective cohort of HIV-infected patients: the Nadis CohortPascal Pugliese, Lise Cuzin, André Cabié, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 14, 2011
Risk factors of chronic kidney disease in HIV-infected patientsPhilippe Flandre, Pascal Pugliese, Lise Cuzin, et al.
Plos One|December 8, 2017
Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational studyLise Cuzin, Pascal Pugliese, Clotilde Allavena, et al.
Plos One|February 3, 2017
Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort studyLaurent Cotte, Tristan Ferry, Pascal Pugliese, et al.
Plos One|October 22, 2015
Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected PatientsIsabelle Poizot-Martin, Alissa Naqvi, Véronique Obry-Roguet, et al.
Plos One|April 19, 2019
Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infectionPierre Gantner, Laurent Cotte, Clotilde Allavena, et al.
Infectious Diseases (London, England)|January 14, 2016
Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIV-1-infected patientsClotilde Allavena, Christine Katlama, Laurent Cotte, et al.
Journal of the International AIDS Society|November 15, 2014
Efficacy and tolerability of Etravirine in HIV-1 adult patients: Results of a large French prospective cohortClotilde Allavena, Christine Katlama, Laurent Cotte, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2011
Human immunodeficiency virus infection and non-small cell lung cancer: survival and toxicity of antineoplastic chemotherapy in a cohort studyAlain Makinson, Jean-Charles Tenon, Sabrina Eymard-Duvernay, et al.
Pageof 5